Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $383.68 | 21 | 96.0% |
| Education | $16.14 | 6 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $191.73 | 10 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $61.21 | 2 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $35.97 | 7 | $0 (2017) |
| Novo Nordisk Inc | $26.38 | 2 | $0 (2017) |
| Amgen Inc. | $16.53 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $15.54 | 1 | $0 (2017) |
| Dexcom, Inc. | $14.62 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $13.36 | 1 | $0 (2017) |
| Lilly USA, LLC | $12.49 | 1 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $11.99 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14.62 | 1 | Dexcom, Inc. ($14.62) |
| 2023 | $28.77 | 2 | AbbVie Inc. ($28.77) |
| 2022 | $149.64 | 7 | ABBVIE INC. ($149.64) |
| 2021 | $13.32 | 1 | AbbVie Inc. ($13.32) |
| 2018 | $61.21 | 2 | Merck Sharp & Dohme Corporation ($61.21) |
| 2017 | $132.26 | 14 | Sunovion Pharmaceuticals Inc. ($35.97) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Endocrinology | ||||||
| 10/12/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: NEUROSCIENCE | ||||||
| 06/22/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: NEUROSCIENCE | ||||||
| 12/21/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.61 | General |
| Category: NEUROSCIENCE | ||||||
| 12/21/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $1.23 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $3.30 | General |
| Category: NEUROSCIENCE | ||||||
| 08/25/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $2.88 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $115.18 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2018 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: WOMENS HEALTH | ||||||
| 08/23/2018 | Merck Sharp & Dohme Corporation | GARDASIL (Biological) | Food and Beverage | In-kind items and services | $44.04 | General |
| Category: VACCINE | ||||||
| 09/14/2017 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Obesity | ||||||
| 09/08/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Respiratory | ||||||
| 08/23/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Education | In-kind items and services | $2.69 | General |
| Category: RESPIRATORY | ||||||
| 08/03/2017 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/12/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Education | In-kind items and services | $2.69 | General |
| Category: RESPIRATORY | ||||||
| 06/08/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Education | In-kind items and services | $2.69 | General |
| Category: RESPIRATORY | ||||||
| 06/02/2017 | Lilly USA, LLC | TRADJENTA (Drug), JENTADUETO, JARDIANCE | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Diabetes | ||||||
| 05/17/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Education | In-kind items and services | $2.69 | General |
| Category: RESPIRATORY | ||||||
| 05/11/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Education | In-kind items and services | $2.69 | General |
| Category: RESPIRATORY | ||||||
| 04/26/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Education | In-kind items and services | $2.69 | General |
| Category: RESPIRATORY | ||||||
| 04/12/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: RESPIRATORY | ||||||
| 04/06/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 977 | 1,294 | $447,971 | $49,812 |
| 2022 | 10 | 851 | 1,085 | $385,478 | $52,239 |
| 2021 | 7 | 567 | 702 | $302,650 | $48,514 |
| 2020 | 8 | 382 | 498 | $186,034 | $30,696 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 364 | 615 | $257,385 | $23,965 | 9.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 181 | 181 | $81,450 | $10,456 | 12.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 193 | 210 | $57,042 | $8,234 | 14.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 30 | 30 | $18,450 | $2,176 | 11.8% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 17 | 58 | $9,512 | $1,631 | 17.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 144 | 144 | $9,360 | $1,260 | 13.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $7,683 | $999.76 | 13.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 21 | 27 | $6,561 | $942.96 | 14.4% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2023 | 14 | 16 | $528.00 | $148.05 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 331 | 542 | $205,833 | $23,024 | 11.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 171 | 171 | $69,939 | $12,270 | 17.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 151 | 172 | $42,316 | $5,595 | 13.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 28 | $28,616 | $4,930 | 17.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 15 | 15 | $6,810 | $1,784 | 26.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 14 | 14 | $9,310 | $1,413 | 15.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 12 | $6,636 | $953.64 | 14.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 105 | 105 | $6,195 | $945.21 | 15.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 13 | $6,950 | $797.34 | 11.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 13 | 13 | $2,873 | $526.55 | 18.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 235 | 361 | $133,306 | $19,279 | 14.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 66 | 67 | $68,474 | $12,684 | 18.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 110 | 110 | $43,670 | $7,200 | 16.5% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 21 | 21 | $17,871 | $3,567 | 20.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 32 | 33 | $17,193 | $2,820 | 16.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 80 | 87 | $20,733 | $2,752 | 13.3% |
About Dr. Tea Tchelidze, MD
Dr. Tea Tchelidze, MD is a Internal Medicine healthcare provider based in Geneva, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508959693.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tea Tchelidze, MD has received a total of $399.82 in payments from pharmaceutical and medical device companies, with $14.62 received in 2024. These payments were reported across 27 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($383.68).
As a Medicare-enrolled provider, Tchelidze has provided services to 2,777 Medicare beneficiaries, totaling 3,579 services with total Medicare billing of $181,261. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Geneva, OH
- Active Since 10/02/2006
- Last Updated 05/21/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1508959693
Products in Payments
- UBRELVY (Drug) $191.73
- GARDASIL (Biological) $44.04
- Saxenda (Drug) $26.38
- BROVANA (Drug) $19.83
- NEXPLANON (Drug) $17.17
- Prolia (Biological) $16.53
- UTIBRON (Drug) $16.14
- SYMBICORT (Drug) $15.54
- Dexcom G6 Transmitter (Medical Supply) $14.62
- ANORO (Drug) $13.36
- TRADJENTA (Drug) $12.49
- PRALUENT (Drug) $11.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Geneva
Dr. Wilfredo Cruz, Md, MD
Internal Medicine — Payments: $41,759
Jason Feinberg, M.d, M.D
Internal Medicine — Payments: $4,475
Dr. Dora Pita-Acevedo, M.d, M.D
Internal Medicine — Payments: $3,217
Jill Cotseones, Do, DO
Internal Medicine — Payments: $2,883
Yasser Mikhail, Md, MD
Internal Medicine — Payments: $1,909
Christine Yu, M.d, M.D
Internal Medicine — Payments: $1,667